In Vitro Diagnostics (IVD) Quality Control Market Growth Accelerates: Strategic Forecast Predicts $2.06 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the In Vitro Diagnostics (IVD) Quality Control Industry Market Size Be by 2025?
In recent times, there has been a significant growth in the size of the in vitro diagnostics (ivd) quality control market. It is forecasted to expand from $1.4 billion in 2024 to $1.48 billion in 2025, at a compound annual growth rate (CAGR) of 5.8%. The growth witnessed in the past can be credited to regulatory compliance, the increasing number of disease cases, a growing elderly population, the expansion of diagnostic labs, as well as a heightened awareness and demand for precision medicine.

What's the Long-Term Growth Forecast for the In Vitro Diagnostics (IVD) Quality Control Market Size Through 2029?
There is an anticipation of robust expansion in the in vitro diagnostics (ivd) quality control market in the coming few years. The anticipated growth is projected to increase the market size to $2.06 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.6%. This projected growth during the forecast period is thought to be due to factors such as advancements in personalized medicine, expansion of point-of-care testing, the integration of digital health, the use of next-generation sequencing (NGS), concerns over global health security, and the incorporation of electronic health records (EHR). Notable trends predicted for the forecast period encompass multi-analyte quality control materials, the use of artificial intelligence and machine learning, the availability of on-demand quality control solutions, continuous monitoring and feedback in real-time, and portable, user-friendly quality control devices.

View the full report here:
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-ivd-quality-control-global-market-report

What Are the Key Growth Drivers Fueling the In Vitro Diagnostics (IVD) Quality Control Market Expansion?
The growing instances of infectious diseases like HIV and cancer are substantially fuelling the expansion of the in vitro diagnostics quality control market. These diseases are prevalent and result from the spread of pathogens such as viruses, bacteria, fungi, or parasites. The surging cases of infectious diseases, including HIV and cancer, demand innovative diagnostic testing products and services for efficient treatment. This in turn, is propelling the need for in vitro diagnostics quality control which guarantees the precision, functionality, and standards of test equipment and outcomes. For instance, as per the data from the Office for National Statistics, a recognized national statistics authority in the UK, the infection rate significantly escalated for individuals aged 35 to 69 years and rose for students in school years 12 to 24 years, at the end of the week concluding on December 9, 2022, in England. Therefore, the growing prevalence of infectious diseases like HIV and cancer is anticipated to stimulate the expansion of the in-vitro diagnostics quality control market throughout the projected years.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5559&type=smp

What Are the Key Trends Driving In Vitro Diagnostics (IVD) Quality Control Market Growth?
The growth of the in vitro diagnostics quality control market is being driven by increased research and development activities. Major firms in the in vitro diagnostics (IVD) quality control sphere are creating unique products to gain a competitive advantage. For example, in November 2023, Newland EMEA, a Dutch digital technology firm, unveiled a new range of in vitro diagnostics (IVD) products at the MEDICA trade event, which comprised five sophisticated barcode scanners specially designed for the healthcare industry. Among these, the fast FM510 and FM530, the adaptable FM550, and the intelligent FM600 camera are intended to boost automation in IVD procedures, enhancing diagnostic speed and precision. This launch highlights Newland EMEA's dedication to progressing automatic identification and data collection technology, ultimately seeking to enhance patient care by providing more efficient healthcare solutions.

How Is the In Vitro Diagnostics (IVD) Quality Control Market Segmented?
The in vitro diagnostics (ivd) quality controlmarket covered in this report is segmented -

1) By Product type: Quality Control Products, Data Management Solutions, Quality Assurance Services
2) By Manufacturer Type: IVD Instrument Manufacturers, Third Party Quality Control Manufacturers
3) By Application: Clinical Chemistry, Hematology, Immunoassay, Molecular Diagnostics, Microbiology, Coagulation Or Hemostasis, Other Applications
4) By End-Users: Hospitals, Clinical Laboratories, Research And Academic Institutes, Other End Users

Subsegments:
1) By Quality Control Products: Control Materials, Quality Control Kits, Proficiency Testing Samples
2) By Data Management Solutions: Software For Quality Control Management, Data Analysis Tools, Cloud-Based Solutions
3) By Quality Assurance Services: Consulting Services, Training And Education Services, Audit And Compliance Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=5559&type=smp

Which Companies Are Leading the Charge in In Vitro Diagnostics (IVD) Quality Control Market Innovation?
Major companies operating in the in vitro diagnostics (IVD) quality control market include Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., LGC Limited., Abbott Laboratories, Roche Diagnostics AG, Siemens AG, Ortho Clinical Diagnostics Inc., Helena Laboratories Corporation, Quidel Corporation, Microbiologics Inc., Sun Diagnostics LLC, Fortress Diagnostics Ltd., Seegene Inc., Bio-Techne Corp., Randox Laboratories, Danaher Corporation, Sysmex Corporation, Beckman Coulter Inc., Grifols India Healthcare Private Limited., Hologic Inc., Qiagen NV, Becton Dickinson and Company, Luminex Corporation, BioMerieux SA, Meridian Bioscience Inc., Sekisui Diagnostics LLC, ZeptoMetrix Corporation, Maine Molecular Quality Controls Inc.

Which Regions Are Leading the Global In Vitro Diagnostics (IVD) Quality Control Market in Revenue?
North America was the largest region in the in vitro diagnostics (IVD) quality control market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostics (IVD) quality control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5559

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay,
Americas: +1 310-496-7795,
Asia: +44 7882 955267 & +91 8897263534,
Europe: +44 7882 955267,
Email: saumyas@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.